Regulation and role of TGFβ production in breast cancer

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 263-276

  Knabbe, C ^a   Kopp, A ^a   Hilgers, W ^a   Lang, D ^a   Muller V ^a   Zugmaier, G ^b   Jonat, W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN BLOOD LEVEL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0029974754     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16241.x     Document Type: Conference Paper

References (34)

1. ALLEGRA, J. C., A. BARLOCK, K. HUFF & M. E. LIPPMAN. 1980. Changes in multiple or sequential estrogen receptor determinations in breast cancer. Cancer 45: 792-798.
2. HENDERSON, I. C. 1993. Adjuvant systemic therapy: overview. Recent Results Cancer Res. 127: 197-200.
3. BONADONNA, G. 1993. What did we learn from the results of the international overview about the effects of endocrine therapy? Recent Results Cancer Res. 127: 159-161.
4. DICKSON, R. B., M. D. JOHNSON, D. EL ASHRY, Y. E. SHI, M. BANO, G. ZUGMAIER, B. ZIFF, M. E. LIPPMAN & S. CHRYSOGELOS. 1993. Breast cancer: influence of endocrine hormones, growth factors, and genetic alterations. Adv. Exp. Med. Biol. 330: 119-141.
5. KNABBE, C. 1991. Regulation of growth inhibitory polypeptides in human breast cancer. In Endocrine-dependent Tumors. K. D. Voigt & C. Knabbe, Eds.: 165-178. Raven Press. New York.
6. WAKEFIELD, L. M., A. A. COLLETTA, B. K. MCCUNE & M. B. SPORN. 1992. Roles for transforming growth factors-β in the genesis, prevention, and treatment of breast cancer. Cancer Treat. Res. 61: 97-136.
7. ZUGMAIER, G., B. E. ENNIS, B. DESCHAUER, D. KATZ, C. KNABBE, G. WILDING, P. DALY, M. E. LIPPMAN & R. B. DICKSON. 1989. Transforming growth factors type β1 and β2 are equipotent inhibitors of human breast cancer cell lines. J. Cell. Physiol. 141: 353-361.
8. KNABBE, C., M. E. LIPPMAN, L. WAKEFIELD, K. FLANDERS, A. KASID, R. DERYNCK & R. B. DICKSON. 1987. Evidence that TGFβ is a hormonally regulated negative growth factor in human breast cancer. Cell 48: 417-428.
9. KASID, A., C. KNABBE & M. E. LIPPMAN. 1987. Effect of v-Ha-ras oncogene transfection on estrogen-independent tumorigenicity of estrogen-dependent human breast cancer cells. Cancer Res. 47: 5733-5738.
10. LAWRENCE, D. A., R. PIRCHER, R. KRYCEVE & P. LULLIEN. 1984. Normal embryo fibroblasts release transforming growth factors in a latent form. J. Cell. Physiol. 121: 184-188.
11. LYONS, R. M., J. KESKI-OJA & H. L. MOSES. 1988. Proteolytic activation of latent transforming growth factor β from fibroblast-conditioned medium. J. Cell Biol. 106: 1659-1665.
12. LOGAN, A. & D. J. HILL. 1992. Bioavailability: is this a key element in regulating the actions of peptide growth factors? J. Endocrinol. 134: 157-161.
13. RODECK, U. R., A. BOSSLER, U. GRAEVEN, F. E. Fox, P. C. NOWELL, C. KNABBE & C. KARI. 1994. Transforming growth factor-β production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res. 54: 575-581.
14. DAUGHADAY, W. H., B. TRIVEDI & M. KAPADIA. 1980. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J. Clin. Endocrinol. Metab. 53: 289-294.
15. BRUNK, C. K., K. C. JONES & T. W. JAMES. 1979. Assay for nanogram quantities of DNA in cellular homogenates. Anal. Chem. 92: 497-500.
16. MANIATIS, T., E. F. FRITSCH & J. SAMBROOK. 1989. Molecular Cloning. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York.
17. AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN, J. A. SMITH & K. STRUHL. 1987. Current Protocols in Molecular Biology. Wiley. New York.
18. DE MARTIN, R., B. HAENDLER, R. HOFER-WARBINEK, H. GAUGITSCH, M. WRANN, H. SCHLUSENER, J. M. SEIFERT, S. BODMER, A. FONTANA & E. HOFER. 1987. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J. 6: 3673-3677.
19. NEVINS, J. R. 1987. Isolation and analysis of nuclear RNA. Methods Enzymol. 152: 234-241.
20. MADISEN, L., N. R. WEBB, T. M. ROSE, H. MARQUARDT, T. IKEDA, D. TWARDZIK, S. SEYEDIN & A. F. PURCHIO. 1988. Transforming growth factor-β2: cDNA cloning and sequence analysis. DNA 7: 1-8.
21. BRONZERT, D. A., G. L. GREENE & M. E. LIPPMAN. 1985. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018. Endocrinology 117: 1409-1417.
22. SATO, Y. & D. B. RIFKIN. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor β-1 molecule by plasmin during coculture. J. Cell Biol. 109: 309-315.
23. BROCK, M. & D. J. SHAPIRO. 1983. Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation. Cell 34: 207-214.
24. SACEDA, M., C. KNABBE, R. B. DICKSON, M. E. LIPPMAN, D. BRONZERT, R. LINDSEY, M. GOTTARDIS & M. B. MARTIN. 1991. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 266: 17809-17814.
25. BEATO, M. 1989. Gene regulation by steroid hormones. Cell 56: 335-355.
26. BERRY, M., D. METZGER & P. CHAMBON. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9: 2811-2818.
27. WISEMAN, L. R., A. E. WAKELING, F. E. B. MAY & B. WESTLEY. 1989. Effects of the antioestrogen ICI 164.384 on oestrogen-induced RNAs in MCF-7 cells. J. Steroid Biochem. 33: 1-6.
28. WAKELING, A. E. & J. BOWLER. 1991. ICI 182.780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol. 43: 173-177.
29. JORDAN, C. & C. S. MURPHY. 1990. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev. 11: 578-610.
30. KNABBE, C., A. KOPP, W. JONAT & G. ZUGMAIER. 1994. Modulation of TGFβ-expression by different members of the steroid hormone family and their antagonists. J. Cell. Biochem. Suppl. 18D: 231.
31. KNABBE, C. & G. ZUGMAIER. 1994. Expression of TGFβ in breast cancer. Endocrine-Related Cancer 1: 5-17.
32. WAKEFIELD, L. M., J. L. LETTERIO, T. CHEN, D. DANIELPOUR, R. S. ALLISON, L. H. PAI, A. M. DENICOFF, M. H. NOONE, K. H. COWAN, J. A. O'SHAUGNESSY & M. B. SPORN. 1995. TGFβ-1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin. Cancer Res. 1: 129-136.
33. COLLETTA, A. A., L. M. WAKEFIELD, F. V. HOWELL, K. E. VAN ROOZENDAAL, D. DANIELPOUR, S. R. EBBS, M. B. SPORN & M. BAUM. 1990. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br. J. Cancer 62: 405-409.
34. BUTTA, A., K. MACLENNAN, K. C. FLANDERS, N. P. SACKS, I. SMITH, A. MCKINNA, M. DOWSETT, L. M. WAKEFIELD, M. B. SPORN, M. BAUM & A. A. COLLETTA. 1992. Induction of transforming growth factor beta-1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 52: 4261-4264.